Structure

Physi-Chem Properties

Molecular Weight:  1840.18
Volume:  1626.613
LogP:  3.927
LogD:  1.435
LogS:  -4.93
# Rotatable Bonds:  14
TPSA:  843.22
# H-Bond Aceptor:  50
# H-Bond Donor:  29
# Rings:  16
# Heavy Atoms:  50

MedChem Properties

QED Drug-Likeness Score:  0.038
Synthetic Accessibility Score:  7.323
Fsp3:  0.146
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  3
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -8.034
MDCK Permeability:  2.502497181922081e-06
Pgp-inhibitor:  0.059
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  1.0
20% Bioavailability (F20%):  0.845
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  98.6027603149414%
Volume Distribution (VD):  -0.641
Pgp-substrate:  1709.306884765625%

ADMET: Metabolism

CYP1A2-inhibitor:  0.334
CYP1A2-substrate:  0.0
CYP2C19-inhibitor:  0.001
CYP2C19-substrate:  0.003
CYP2C9-inhibitor:  0.038
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.011
CYP3A4-inhibitor:  0.0
CYP3A4-substrate:  0.0

ADMET: Excretion

Clearance (CL):  14.063
Half-life (T1/2):  0.976

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.544
Drug-inuced Liver Injury (DILI):  1.0
AMES Toxicity:  0.04
Rat Oral Acute Toxicity:  0.0
Maximum Recommended Daily Dose:  0.138
Skin Sensitization:  0.993
Carcinogencity:  0.002
Eye Corrosion:  0.003
Eye Irritation:  0.98
Respiratory Toxicity:  0.0

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC174140

Natural Product ID:  NPC174140
Common Name*:   Gemin A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  NYVCMROWMXMBDJ-KGLDGZCVSA-N
Standard InCHI:  InChI=1S/C82H56O50/c83-26-1-16(2-27(84)47(26)95)73(112)127-69-67-39(14-120-65-19-7-31(88)50(98)57(105)41(19)42-20(66(65)125-67)8-32(89)51(99)58(42)106)123-81(71(69)129-74(113)17-3-28(85)48(96)29(86)4-17)131-75(114)18-5-30(87)49(97)38(6-18)122-64-25(13-37(94)56(104)63(64)111)80(119)132-82-72-70(128-78(117)23-11-35(92)54(102)61(109)45(23)46-24(79(118)130-72)12-36(93)55(103)62(46)110)68-40(124-82)15-121-76(115)21-9-33(90)52(100)59(107)43(21)44-22(77(116)126-68)10-34(91)53(101)60(44)108/h1-13,39-40,67-72,81-111H,14-15H2/t39-,40-,67-,68-,69+,70+,71-,72-,81-,82+/m1/s1
SMILES:  c1c(cc(c(c1O)O)O)C(=O)O[C@H]1[C@H]2[C@@H](COc3c4cc(c(c(c4c4c(cc(c(c4O)O)O)c3O2)O)O)O)O[C@@H]([C@@H]1OC(=O)c1cc(c(c(c1)O)O)O)OC(=O)c1cc(c(c(c1)Oc1c(cc(c(c1O)O)O)C(=O)O[C@H]1[C@H]2[C@H]([C@H]3[C@@H](COC(=O)c4cc(c(c(c4-c4c(cc(c(c4O)O)O)C(=O)O3)O)O)O)O1)OC(=O)c1cc(c(c(c1-c1c(cc(c(c1O)O)O)C(=O)O2)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449414
PubChem CID:   44575173
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. whole plant n.a. DOI[10.1021/np50028a032]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. whole plant n.a. PMID[10993241]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[16643063]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[16989532]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[24256496]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota leaves and vine stems Xishuangbanna Tropical Botanical Garden (XTBG), Chinese Academy of Science (CAS), Mengla County, Yunnan Province, China 2009-OCT PMID[26103517]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[26222693]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. PMID[8759159]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. whole plant n.a. PMID[8759159]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. PMID[9834152]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28301 Clerodendron cyrtophyllum n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO28301 Clerodendron cyrtophyllum n.a. n.a. n.a. n.a. n.a. n.a. Database[TCMID]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO3129 Geum japonicum Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT547 Cell Line BGC-823 Homo sapiens IC50 = 40400.0 nM PMID[497458]
NPT2 Others Unspecified Activity = 106.0 % PMID[497457]
NPT2 Others Unspecified Activity = 1.0 % PMID[497457]
NPT2 Others Unspecified Activity = 3.0 % PMID[497457]
NPT2 Others Unspecified Activity = 16.0 % PMID[497457]
NPT2 Others Unspecified Activity = 19.0 % PMID[497457]
NPT2 Others Unspecified Activity = 70.0 % PMID[497457]
NPT2 Others Unspecified Activity = 60.0 % PMID[497457]
NPT2 Others Unspecified Activity = 6.0 % PMID[497457]
NPT2 Others Unspecified Inhibition = 70.0 % PMID[497457]
NPT2 Others Unspecified IC50 = 210.0 nM PMID[497458]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC174140 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9665 High Similarity NPC471091
0.9665 High Similarity NPC97924
0.9665 High Similarity NPC40078
0.9553 High Similarity NPC240200
0.9553 High Similarity NPC158214
0.9553 High Similarity NPC223534
0.9553 High Similarity NPC290289
0.95 High Similarity NPC469652
0.95 High Similarity NPC160543
0.95 High Similarity NPC472720
0.95 High Similarity NPC472724
0.95 High Similarity NPC31208
0.95 High Similarity NPC93065
0.95 High Similarity NPC187632
0.95 High Similarity NPC472721
0.9497 High Similarity NPC260521
0.9497 High Similarity NPC469649
0.9348 High Similarity NPC189312
0.9344 High Similarity NPC477082
0.9333 High Similarity NPC261623
0.9333 High Similarity NPC111490
0.9333 High Similarity NPC469650
0.9243 High Similarity NPC3474
0.9235 High Similarity NPC264302
0.9231 High Similarity NPC269046
0.9231 High Similarity NPC477081
0.9231 High Similarity NPC477083
0.9176 High Similarity NPC65489
0.9176 High Similarity NPC237202
0.9167 High Similarity NPC8940
0.9111 High Similarity NPC472725
0.9111 High Similarity NPC472726
0.9071 High Similarity NPC179947
0.9066 High Similarity NPC231254
0.9022 High Similarity NPC473618
0.9016 High Similarity NPC112380
0.9016 High Similarity NPC473686
0.9016 High Similarity NPC475220
0.9016 High Similarity NPC221140
0.9016 High Similarity NPC229817
0.9016 High Similarity NPC475352
0.9011 High Similarity NPC123259
0.9011 High Similarity NPC129533
0.9006 High Similarity NPC80956
0.8973 High Similarity NPC201814
0.8967 High Similarity NPC105591
0.8962 High Similarity NPC49690
0.8956 High Similarity NPC125352
0.8956 High Similarity NPC470453
0.8956 High Similarity NPC470448
0.8956 High Similarity NPC164047
0.8956 High Similarity NPC470452
0.893 High Similarity NPC476358
0.8913 High Similarity NPC87583
0.8907 High Similarity NPC476203
0.8907 High Similarity NPC473631
0.8907 High Similarity NPC293227
0.8907 High Similarity NPC475662
0.8907 High Similarity NPC473717
0.8901 High Similarity NPC84494
0.8901 High Similarity NPC245059
0.8895 High Similarity NPC472723
0.8895 High Similarity NPC297574
0.8883 High Similarity NPC47521
0.8865 High Similarity NPC269625
0.8846 High Similarity NPC476622
0.8846 High Similarity NPC476621
0.8846 High Similarity NPC265380
0.8846 High Similarity NPC476623
0.8846 High Similarity NPC476620
0.8846 High Similarity NPC476619
0.8846 High Similarity NPC476618
0.8833 High Similarity NPC100251
0.8824 High Similarity NPC321046
0.8817 High Similarity NPC119094
0.8817 High Similarity NPC7839
0.8817 High Similarity NPC173872
0.8817 High Similarity NPC142291
0.8811 High Similarity NPC241847
0.8804 High Similarity NPC132111
0.8798 High Similarity NPC185275
0.8798 High Similarity NPC212290
0.8791 High Similarity NPC67629
0.8791 High Similarity NPC79736
0.8785 High Similarity NPC98583
0.8771 High Similarity NPC190204
0.8771 High Similarity NPC43918
0.8771 High Similarity NPC261411
0.8757 High Similarity NPC318119
0.875 High Similarity NPC477860
0.875 High Similarity NPC53680
0.875 High Similarity NPC117668
0.875 High Similarity NPC475161
0.875 High Similarity NPC208797
0.8743 High Similarity NPC267549
0.8743 High Similarity NPC471789
0.8743 High Similarity NPC472387
0.8736 High Similarity NPC470454
0.8736 High Similarity NPC63105
0.8736 High Similarity NPC199533
0.8729 High Similarity NPC65333
0.8722 High Similarity NPC149300
0.8717 High Similarity NPC205721
0.8703 High Similarity NPC150977
0.8703 High Similarity NPC321916
0.8698 High Similarity NPC470450
0.8696 High Similarity NPC471030
0.8696 High Similarity NPC114257
0.8696 High Similarity NPC299149
0.8696 High Similarity NPC324742
0.8696 High Similarity NPC277710
0.8696 High Similarity NPC153578
0.8689 High Similarity NPC472992
0.8689 High Similarity NPC92403
0.8689 High Similarity NPC66820
0.8689 High Similarity NPC170018
0.8689 High Similarity NPC216307
0.8689 High Similarity NPC76112
0.8689 High Similarity NPC46958
0.8689 High Similarity NPC472991
0.8681 High Similarity NPC473550
0.8667 High Similarity NPC31034
0.8667 High Similarity NPC217781
0.8667 High Similarity NPC470271
0.8667 High Similarity NPC311389
0.8663 High Similarity NPC475179
0.8656 High Similarity NPC472722
0.8649 High Similarity NPC469371
0.8649 High Similarity NPC265795
0.8634 High Similarity NPC68381
0.8634 High Similarity NPC3718
0.8634 High Similarity NPC146803
0.8626 High Similarity NPC102851
0.8626 High Similarity NPC81332
0.8626 High Similarity NPC212038
0.8626 High Similarity NPC477836
0.8626 High Similarity NPC5786
0.8626 High Similarity NPC47140
0.8626 High Similarity NPC262580
0.8626 High Similarity NPC67134
0.8626 High Similarity NPC271848
0.8626 High Similarity NPC289396
0.8619 High Similarity NPC198125
0.8619 High Similarity NPC95421
0.8611 High Similarity NPC49983
0.8611 High Similarity NPC26536
0.8611 High Similarity NPC142707
0.8611 High Similarity NPC317671
0.8611 High Similarity NPC175793
0.861 High Similarity NPC474093
0.861 High Similarity NPC104910
0.8602 High Similarity NPC297503
0.8602 High Similarity NPC97119
0.8602 High Similarity NPC470718
0.8602 High Similarity NPC135831
0.8595 High Similarity NPC58538
0.8595 High Similarity NPC473785
0.8587 High Similarity NPC475246
0.8587 High Similarity NPC102053
0.8587 High Similarity NPC255799
0.8579 High Similarity NPC25724
0.8579 High Similarity NPC213052
0.8579 High Similarity NPC219600
0.8579 High Similarity NPC34436
0.8579 High Similarity NPC263119
0.8579 High Similarity NPC88560
0.8579 High Similarity NPC166674
0.8579 High Similarity NPC46640
0.8579 High Similarity NPC175230
0.8579 High Similarity NPC172033
0.8571 High Similarity NPC52598
0.8571 High Similarity NPC181778
0.8571 High Similarity NPC34287
0.8571 High Similarity NPC149011
0.8571 High Similarity NPC314672
0.8571 High Similarity NPC471416
0.8571 High Similarity NPC204937
0.8571 High Similarity NPC298778
0.8571 High Similarity NPC476365
0.8571 High Similarity NPC470272
0.8564 High Similarity NPC30011
0.8564 High Similarity NPC97817
0.8564 High Similarity NPC64755
0.8564 High Similarity NPC473818
0.8564 High Similarity NPC72554
0.8556 High Similarity NPC148710
0.8556 High Similarity NPC470451
0.8556 High Similarity NPC470455
0.8556 High Similarity NPC470713
0.8556 High Similarity NPC460984
0.8556 High Similarity NPC470416
0.8556 High Similarity NPC25946
0.8556 High Similarity NPC162169
0.8556 High Similarity NPC470720
0.8556 High Similarity NPC470717
0.8556 High Similarity NPC166851
0.8556 High Similarity NPC224557
0.8556 High Similarity NPC21359
0.8556 High Similarity NPC292706
0.8541 High Similarity NPC207467

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC174140 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8757 High Similarity NPD8397 Clinical (unspecified phase)
0.8689 High Similarity NPD8313 Approved
0.8689 High Similarity NPD8312 Approved
0.8424 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8415 Intermediate Similarity NPD5844 Phase 1
0.8384 Intermediate Similarity NPD8151 Discontinued
0.837 Intermediate Similarity NPD7074 Phase 3
0.837 Intermediate Similarity NPD7472 Approved
0.8368 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8315 Intermediate Similarity NPD7054 Approved
0.8287 Intermediate Similarity NPD6959 Discontinued
0.8268 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6232 Discontinued
0.8235 Intermediate Similarity NPD7808 Phase 3
0.8207 Intermediate Similarity NPD7473 Discontinued
0.8182 Intermediate Similarity NPD7251 Discontinued
0.8162 Intermediate Similarity NPD3818 Discontinued
0.8128 Intermediate Similarity NPD6797 Phase 2
0.8065 Intermediate Similarity NPD7228 Approved
0.8056 Intermediate Similarity NPD1465 Phase 2
0.8054 Intermediate Similarity NPD6166 Phase 2
0.8054 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.803 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.803 Intermediate Similarity NPD7783 Phase 2
0.8021 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD6559 Discontinued
0.7956 Intermediate Similarity NPD8455 Phase 2
0.7923 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD7435 Discontinued
0.7861 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7819 Suspended
0.7838 Intermediate Similarity NPD5494 Approved
0.7824 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7822 Intermediate Similarity NPD7870 Phase 2
0.7822 Intermediate Similarity NPD7871 Phase 2
0.7802 Intermediate Similarity NPD1934 Approved
0.7784 Intermediate Similarity NPD6234 Discontinued
0.7772 Intermediate Similarity NPD7698 Approved
0.7772 Intermediate Similarity NPD7768 Phase 2
0.7772 Intermediate Similarity NPD7696 Phase 3
0.7772 Intermediate Similarity NPD7697 Approved
0.776 Intermediate Similarity NPD2801 Approved
0.773 Intermediate Similarity NPD7075 Discontinued
0.7718 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD7874 Approved
0.7711 Intermediate Similarity NPD6776 Approved
0.7711 Intermediate Similarity NPD6779 Approved
0.7711 Intermediate Similarity NPD6781 Approved
0.7711 Intermediate Similarity NPD6777 Approved
0.7711 Intermediate Similarity NPD6782 Approved
0.7711 Intermediate Similarity NPD6780 Approved
0.7711 Intermediate Similarity NPD6778 Approved
0.7708 Intermediate Similarity NPD7240 Approved
0.7707 Intermediate Similarity NPD7701 Phase 2
0.7622 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7612 Intermediate Similarity NPD7699 Phase 2
0.7612 Intermediate Similarity NPD7700 Phase 2
0.7609 Intermediate Similarity NPD37 Approved
0.7596 Intermediate Similarity NPD4380 Phase 2
0.7581 Intermediate Similarity NPD4965 Approved
0.7581 Intermediate Similarity NPD4966 Approved
0.7581 Intermediate Similarity NPD4967 Phase 2
0.7568 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD7411 Suspended
0.7549 Intermediate Similarity NPD6823 Phase 2
0.754 Intermediate Similarity NPD3749 Approved
0.7527 Intermediate Similarity NPD3817 Phase 2
0.7523 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7199 Phase 2
0.7512 Intermediate Similarity NPD7801 Approved
0.75 Intermediate Similarity NPD3751 Discontinued
0.7487 Intermediate Similarity NPD3882 Suspended
0.7486 Intermediate Similarity NPD1653 Approved
0.7476 Intermediate Similarity NPD8320 Phase 1
0.7476 Intermediate Similarity NPD8319 Approved
0.7474 Intermediate Similarity NPD3787 Discontinued
0.7463 Intermediate Similarity NPD6535 Approved
0.7463 Intermediate Similarity NPD6534 Approved
0.7459 Intermediate Similarity NPD7390 Discontinued
0.7436 Intermediate Similarity NPD7685 Pre-registration
0.7435 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD5402 Approved
0.7424 Intermediate Similarity NPD8150 Discontinued
0.7418 Intermediate Similarity NPD2532 Approved
0.7418 Intermediate Similarity NPD2534 Approved
0.7418 Intermediate Similarity NPD2533 Approved
0.7363 Intermediate Similarity NPD1511 Approved
0.7351 Intermediate Similarity NPD7458 Discontinued
0.7343 Intermediate Similarity NPD7680 Approved
0.7337 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD6801 Discontinued
0.7322 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD1512 Approved
0.7258 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD3226 Approved
0.7241 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6212 Phase 3
0.7241 Intermediate Similarity NPD6213 Phase 3
0.7228 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6599 Discontinued
0.7182 Intermediate Similarity NPD1549 Phase 2
0.7167 Intermediate Similarity NPD5405 Approved
0.7167 Intermediate Similarity NPD5406 Approved
0.7167 Intermediate Similarity NPD5404 Approved
0.7167 Intermediate Similarity NPD5408 Approved
0.7143 Intermediate Similarity NPD6674 Discontinued
0.7135 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD3750 Approved
0.7088 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6799 Approved
0.7079 Intermediate Similarity NPD8434 Phase 2
0.7072 Intermediate Similarity NPD2935 Discontinued
0.7062 Intermediate Similarity NPD1247 Approved
0.7059 Intermediate Similarity NPD5403 Approved
0.7047 Intermediate Similarity NPD919 Approved
0.7043 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.704 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.704 Intermediate Similarity NPD8059 Phase 3
0.7033 Intermediate Similarity NPD7266 Discontinued
0.7033 Intermediate Similarity NPD2346 Discontinued
0.7033 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7028 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD5710 Approved
0.7026 Intermediate Similarity NPD5711 Approved
0.7011 Intermediate Similarity NPD4628 Phase 3
0.7011 Intermediate Similarity NPD7003 Approved
0.699 Remote Similarity NPD3926 Phase 2
0.698 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6978 Remote Similarity NPD1551 Phase 2
0.6974 Remote Similarity NPD8127 Discontinued
0.6973 Remote Similarity NPD6190 Approved
0.6971 Remote Similarity NPD8090 Clinical (unspecified phase)
0.697 Remote Similarity NPD7177 Discontinued
0.6957 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6952 Remote Similarity NPD5401 Approved
0.6944 Remote Similarity NPD230 Phase 1
0.6939 Remote Similarity NPD7229 Phase 3
0.6923 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6923 Remote Similarity NPD1510 Phase 2
0.6919 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6916 Remote Similarity NPD7584 Approved
0.6906 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6885 Remote Similarity NPD2796 Approved
0.6851 Remote Similarity NPD1933 Approved
0.6849 Remote Similarity NPD7930 Approved
0.6831 Remote Similarity NPD2799 Discontinued
0.6831 Remote Similarity NPD3748 Approved
0.6828 Remote Similarity NPD8166 Discontinued
0.6828 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6825 Remote Similarity NPD8285 Discontinued
0.6813 Remote Similarity NPD1607 Approved
0.6806 Remote Similarity NPD7585 Approved
0.6796 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6796 Remote Similarity NPD1613 Approved
0.6796 Remote Similarity NPD943 Approved
0.6793 Remote Similarity NPD8153 Approved
0.6793 Remote Similarity NPD8152 Approved
0.6789 Remote Similarity NPD920 Approved
0.6782 Remote Similarity NPD5953 Discontinued
0.6772 Remote Similarity NPD642 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7286 Phase 2
0.6763 Remote Similarity NPD4287 Approved
0.6759 Remote Similarity NPD7583 Approved
0.6758 Remote Similarity NPD447 Suspended
0.6739 Remote Similarity NPD651 Clinical (unspecified phase)
0.6716 Remote Similarity NPD7549 Discontinued
0.6704 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6703 Remote Similarity NPD1240 Approved
0.6703 Remote Similarity NPD6100 Approved
0.6703 Remote Similarity NPD6099 Approved
0.6685 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6684 Remote Similarity NPD2800 Approved
0.6684 Remote Similarity NPD1243 Approved
0.6667 Remote Similarity NPD7907 Approved
0.6667 Remote Similarity NPD643 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6652 Remote Similarity NPD8067 Phase 3
0.6651 Remote Similarity NPD5006 Approved
0.6651 Remote Similarity NPD5005 Approved
0.6649 Remote Similarity NPD6273 Approved
0.6636 Remote Similarity NPD7999 Approved
0.6634 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6633 Remote Similarity NPD5353 Approved
0.6595 Remote Similarity NPD7097 Phase 1
0.6593 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6593 Remote Similarity NPD2313 Discontinued
0.6567 Remote Similarity NPD5242 Approved
0.6564 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6555 Remote Similarity NPD6841 Approved
0.6555 Remote Similarity NPD6843 Phase 3
0.6555 Remote Similarity NPD6842 Approved
0.6542 Remote Similarity NPD4420 Approved
0.6538 Remote Similarity NPD3027 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data